BioCentury
ARTICLE | Company News

Alteon, HaptoGuard deal

April 24, 2006 7:00 AM UTC

ALT said it will acquire inflammation and cardiovascular company HaptoGuard in a stock deal. ALT will issue $5.3 million of stock (about 22.5 million shares) to HaptoGuard shareholders. Also, HaptoGuard shareholders will receive an additional $3.5 million of ALT stock that is currently held by Genentech Inc. (DNA, South San Francisco, Calif.). All told, HaptoGuard shareholders will own 31% of the combined company. ...